Pomegranate extract and exercise provide additive benefits on improvement of immune function by inhibiting inflammation and oxidative stress in high-fat-diet-induced obesity rats

Journal of Nutritional Biochemistry

Volumn 32, Issue , 2016, Pages 20-28

  Zhao, Fei ^a   Pang, Wentao ^a   Zhang, Ziyi ^a   Zhao, Jialong ^a   Wang, Xin ^c   Liu, Ye ^b   Wang, Xun ^b   Feng, Zhihui ^b   Zhang, Yong ^a,b   Sun, Wenyan ^b   Liu, Jiankang ^a,b  

^a TIANJIN UNIVERSITY OF SPORT   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Exercise; Immune function; Inflammation; Obesity; Oxidative stress; Pomegranate extract

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; LEPTIN; POMEGRANATE EXTRACT; TUMOR NECROSIS FACTOR ALPHA; ANTIOBESITY AGENT; ANTIOXIDANT; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; PUNICALAGIN; TANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; EXERCISE; HISTOPATHOLOGY; IMMUNE DEFICIENCY; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; LIPID DIET; MALE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEUM MACROPHAGE; PROTEIN BLOOD LEVEL; RAT; SPLEEN; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; WEIGHT REDUCTION; ADVERSE EFFECTS; ANALYSIS; ANIMAL; CD4 CD8 RATIO; CHEMISTRY; COMPARATIVE STUDY; DIET THERAPY; DIETARY SUPPLEMENT; IMMUNOLOGY; INNATE IMMUNITY; LYTHRACEAE; METABOLISM; MONONUCLEAR CELL; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; WEIGHT GAIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-OBESITY AGENTS; ANTIOXIDANTS; CD4-CD8 RATIO; COMBINED MODALITY THERAPY; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; HYDROLYZABLE TANNINS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; MACROPHAGES, PERITONEAL; MALE; OBESITY; OXIDATIVE STRESS; PHYSICAL CONDITIONING, ANIMAL; PLANT EXTRACTS; PUNICACEAE; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; SPLEEN; WEIGHT GAIN;

EID: 84961139629     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2016.02.003     Document Type: Article

References (28)

1. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007, 298:2028-2037.
2. Tanaka S., Isoda F., Ishihara Y., Kimura M., Yamakawa T. T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective. Clin Endocrinol (Oxf) 2001, 54:347-354.
3. Amar S., Zhou Q., Shaik-Dasthagirisaheb Y., Leeman S. Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc Natl Acad Sci U S A 2007, 104:20466-20471.
4. Smith A.G., Sheridan P.A., Harp J.B., Beck M.A. Diet-induced obese mice have increased mortality and altered immune responses when infected with influenza virus. J Nutr 2007, 137:1236-1243.
5. Marti A., Marcos A., Martinez J.A. Obesity and immune function relationships. obesity reviews: an official journal of the international association for the study of. Obesity 2001, 2:131-140.
6. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S.L., et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002, 8:75-79.
7. Chida D., Osaka T., Hashimoto O., Iwakura Y. Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice. Diabetes 2006, 55:971-977.
8. Netea M.G., Joosten L.A., Lewis E., Jensen D.R., Voshol P.J., Kullberg B.J., et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 2006, 12:650-656.
9. Li Z.Y., Wang P., Miao C.Y. Adipokines in inflammation, insulin resistance and cardiovascular disease. Cli Exp Pharmacol P 2011, 38(12):888-896.
10. Pedersen B.K., Febbraio M.A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 2012, 8(8):457-465.
11. Kasim-Karakas S.E., Tsodikov A., Singh U., Jialal I. Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake. Am J Clin Nutr 2006, 83(4):774-779.
12. Baumgarner K.M., Setti S., Diaz C., Littlefield A., Jones A., Kohman R.A. Diet-induced obesity attenuates cytokine production following an immune challenge. Behav Brain Res 2014, 1(267):33-41.
13. Zou X., Yan C., Shi Y., Cao K., Xu J., Wang X., et al. Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin. Antioxid Redox Sign 2014, 21:1557-1570.
14. Vroegrijk I.O., van Diepen J.A., van den Berg S., Westbroek I., Keizer H., Gambelli L., et al. Pomegranate seed oil, a rich source of punicic acid, prevents diet-induced obesity and insulin resistance in mice. Food Chem Toxicol 2011, 49:1426-1430.
15. Woo K.S., Chook P., Yu C.W., Sung R.Y., Qiao M., Leung S.S., et al. Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004, 109:1981-1986.
16. Bedford T.G., Tipton C.M., Wilson N.C., Oppliger R.A., Gisolfi C.V. Maximum oxygen consumption of rats and its changes with various experimental procedures. J Appl Physiol Respir Environ Exerc Physiol 1979, 47(6):1278-1283.
17. Tanaka S., Isoda F., Yamakawa T., Ishihara M., Sekihara H. T lymphopenia in genetically obese rats. Clin Immunol Immnopathol 1998, 86:219-225.
18. Yamasaki M., Kitagawa T., Koyanagi N., Chujo H., Maeda H., Kohno-Murase J., et al. Dietary effect of pomegranate seed oil on immune function and lipid metabolism in mice. Nutrition 2006, 22:54-59.
19. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964.
20. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
21. Shaul M.E., Bennett G., Strissel K.J., Greenberg A.S., Obin M.S. Dynamic, M2-like remodeling phenotypes of CD11c + adipose tissue macrophages during high-fat diet-induced obesity in mice. Diabetes 2010, 59:1171-1181.
22. Haase J., Weyer U., Immig K., Kloting N., Bluher M., Eilers J., et al. Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. Diab Tologia 2014, 57:562-571.
23. Gundra U.M., Girgis N.M., Ruckerl D., Jenkins S., Ward L.N., Kurtz Z.D., et al. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood 2014, 123:e110-e122.
24. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011, 11:85-97.
25. Misra A., Garg A. Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature. Medicine (Baltimore) 2003, 82:129-146.
26. Tilg H., Hotamisligil G.S. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 2006, 131:934-945.
27. Esposito K., Ciotola M., Schisano B., Misso L., Giannetti G., Ceriello A., et al. Oxidative stress in the metabolic syndrome. J Endocrinol Invest 2006, 29:791-795.
28. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004, 114:1752-1761.